α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions

被引:57
作者
Sang, Peng [4 ]
Shi, Yan [4 ]
Lu, Junhao [3 ]
Chen, Lihong [3 ]
Yang, Leixiang [3 ]
Borcherds, Wade [2 ]
Abdulkadir, Sami [4 ]
Li, Qi [1 ]
Daughdrill, Gary [2 ]
Chen, Jiandong [3 ]
Cai, Jianfeng [4 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai 201203, Peoples R China
[2] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA
[4] Univ S Florida, Dept Chem, Tampa, FL 33620 USA
关键词
AROMATIC OLIGOAMIDE FOLDAMERS; STRUCTURE-BASED DESIGN; BETA(3)-PEPTIDE INHIBITORS; TRANSMEMBRANE PORES; BETA-PEPTIDES; P53; AFFINITY; MIMETICS; MDMX; PEPTOIDS;
D O I
10.1021/acs.jmedchem.9b00993
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The use of peptidomimetic scaffolds is a promising strategy for the inhibition of protein-protein interactions (PPIs). Herein, we demonstrate that sulfono-gamma-AApeptides can be rationally designed to mimic the p53 alpha-helix and inhibit p53 MDM2 PPIs. The best inhibitor, with K-d and IC50 values of 26 nM and 0.891 mu M toward MDM2, respectively, is among the most potent unnatural peptidomimetic inhibitors disrupting the p53-MDM2/MDMX interaction. Using fluorescence polarization assays, circular dichroism, nuclear magnetic resonance spectroscopy, and computational simulations, we demonstrate that sulfono-gamma-AApeptides adopt helical structures resembling p53 and competitively inhibit the p53-MDM2 interaction by binding to the hydrophobic cleft of MDM2. Intriguingly, the stapled sulfono-gamma-AApeptides showed promising cellular activity by enhancing p53 transcriptional activity and inducing expression of MDM2 and p21. Moreover, sulfono-gamma-AApeptides exhibited remarkable resistance to proteolysis, augmenting their biological potential. Our results suggest that sulfono-gamma-AApeptides are a new class of unnatural helical foldamers that disrupt PPIs.
引用
收藏
页码:975 / 986
页数:12
相关论文
共 50 条
[21]   Calculation of Hot Spots for Protein-Protein Interaction in p53/PMI-MDM2/MDMX Complexes [J].
Huang, Dading ;
Qi, Yifei ;
Song, Jianing ;
Zhang, John Z. H. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2019, 40 (09) :1045-1056
[22]   The p53-MDM2/MDMX axis - A chemotype perspective [J].
Khoury, Kareem ;
Popowicz, Grzegorz M. ;
Holak, Tad A. ;
Doemling, Alexander .
MEDCHEMCOMM, 2011, 2 (04) :246-260
[23]   Selective and Potent Morpholinone Inhibitors of the MDM2-p53 Protein-Protein Interaction [J].
Gonzalez, Ana Z. ;
Eksterowicz, John ;
Bartberger, Michael D. ;
Beck, Hilary P. ;
Canon, Jude ;
Chen, Ada ;
Chow, David ;
Duquette, Jason ;
Fox, Brian M. ;
Fu, Jiasheng ;
Huang, Xin ;
Houze, Jonathan B. ;
Jin, Lixia ;
Li, Yihong ;
Li, Zhihong ;
Ling, Yun ;
Lo, Mei-Chu ;
Long, Alexander M. ;
McGee, Lawrence R. ;
McIntosh, Joel ;
McMinn, Dustin L. ;
Oliner, Jonathan D. ;
Osgood, Tao ;
Rew, Yosup ;
Saiki, Anne Y. ;
Shaffer, Paul ;
Wortman, Sarah ;
Yakowec, Peter ;
Yan, Xuelei ;
Ye, Qiuping ;
Yu, Dongyin ;
Zhao, Xiaoning ;
Zhou, Jing ;
Olson, Steven H. ;
Medina, Julio C. ;
Sun, Daqing .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) :2472-2488
[24]   Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation [J].
Xia, Mingxuan ;
Knezevic, Dejan ;
Tovar, Christian ;
Huang, Baoying ;
Heimbrook, David C. ;
Vassilev, Lyubomir T. .
CELL CYCLE, 2008, 7 (11) :1604-1612
[25]   Discovery of novel dihydroimidazothiazole derivatives as p53-MDM2 protein-protein interaction inhibitors: Synthesis, biological evaluation and structure-activity relationships [J].
Miyazaki, Masaki ;
Kawato, Haruko ;
Naito, Hiroyuki ;
Ikeda, Masahiro ;
Miyazaki, Masaya ;
Kitagawa, Mayumi ;
Seki, Takahiko ;
Fukutake, Setsuko ;
Aonuma, Masashi ;
Soga, Tsunehiko .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (20) :6338-6342
[26]   Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction [J].
Zhuang, Chunlin ;
Miao, Zhenyuan ;
Zhu, Lingjian ;
Zhang, Yongqiang ;
Guo, Zizhao ;
Yao, Jianzhong ;
Dong, Guoqiang ;
Wang, Shengzheng ;
Liu, Yang ;
Chen, Hai ;
Sheng, Chunquan ;
Zhang, Wannian .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) :5654-5661
[27]   Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition [J].
Madden, Michael M. ;
Muppidi, Avinash ;
Li, Zhenyu ;
Li, Xiaolong ;
Chen, Jiandong ;
Lin, Qing .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) :1472-1475
[28]   Structure-activity relationship and antitumor activity of thio-benzodiazepines as p53-MDM2 protein-protein interaction inhibitors [J].
Guo, Zizhao ;
Zhuang, Chunlin ;
Zhu, Lingjian ;
Zhang, Yongqiang ;
Yao, Jianzhong ;
Dong, Guoqiang ;
Wang, Shengzheng ;
Liu, Yang ;
Chen, Hai ;
Sheng, Chunquan ;
Miao, Zhenyuan ;
Zhang, Wannian .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 56 :10-16
[29]   Elaboration of Non-naturally Occurring Helical Tripeptides as p53-MDM2/MDMX Interaction Inhibitors [J].
Su, Aoze ;
Tabata, Yuko ;
Aoki, Kiyono ;
Sada, Akane ;
Ohki, Rieko ;
Nagatoishi, Satoru ;
Tsumoto, Kouhei ;
Wang, Siyuan ;
Otani, Yuko ;
Ohwada, Tomohiko .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2021, 69 (07) :681-692
[30]   Environment-sensitive turn-on fluorescent probes for p53-MDM2 protein-protein interaction [J].
Liu, Tingting ;
Jiang, Yan ;
Liu, Zhenzhen ;
Li, Jin ;
Fang, Kun ;
Zhuang, Chunlin ;
Du, Lupei ;
Fang, Hao ;
Sheng, Chunquan ;
Li, Minyong .
MEDCHEMCOMM, 2017, 8 (08) :1668-1672